GlassScriptPhysician profile
Marmar Vaseghi
NPI 1447493432
$60,645.67
in general payments reported to CMS, 2019-2025
9 companies · $15K in 2025
The $15K reported for 2025 was more than what 86% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,633 · 2021: $1,820 · 2022: $16K · 2023: $7,527 · 2024: $15K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $18K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,963 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,469 · Travel and Lodging: $3,690 · Food and Beverage: $2,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $17,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,963.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,468.75 |
| Travel and Lodging | $3,689.99 |
| Food and Beverage | $2,102.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22,500.00 | 2022-2025 | Lifevest |
| Medtronic, INC. | $17,185.84 | 2022-2024 | Arctic Front Advance, Pulseselect, Na |
| Abbott Laboratories | $14,663.29 | 2019-2025 | Ensite Precision, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Biosense Webster, INC. | $5,737.50 | 2021-2022 | |
| Penumbra, INC. | $234.54 | 2022 | |
| Cardiva Medical, INC. | $233.99 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Boston Scientific Corporation | $59.08 | 2023-2025 | Watchman |
| Janssen Pharmaceuticals, INC | $31.43 | 2024 | Xarelto |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marmar Vaseghi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.